KalVista Pharmaceuticals, Inc. (KALV)

16.02 -0.52 (-3.14%) USD  |  NASDAQ  |  Jan 23, 16:00
16.02 0.00 (0.00%) After-Hours: 20:00
More

KalVista Pharmaceuticals Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Silvergate Capital Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade